Sarah joined the pharmaceutical industry in 1998, working in Business Development at a global CRO where she led the North American proposal team for Clinical Development services. In 2005, she joined Bristol-Myers Squibb where she worked in Finance, Clinical Operations, and Alliance Management. Sarah joined BioWa/Kyowa Kirin in 2020 and was named President of BioWa (Kyowa Kirin’s technology licensing business) in 2021. In addition to managing the BioWa business, she and her team also lead business development and alliance management activities for Kyowa Kirin North America.